TGFB1 and neoplasm: Although tumor antigen bypasses or breaks through the first immunosuppression barrier to prime and activate the antigen immunity, TGF-β can suppress igniting CRI by decreasing total effector immune cells repertoire by reducing IL-2 secreted (118).